Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids[S]

Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids[S]

Beneficial physiological effects of long-chain n-3 polyunsaturated fatty acids are widely accepted but the mechanism(s) by which these fatty acids act remains unclear. Herein, we report the presence, distribution, and regulation of the levels of n-3 epoxy-fatty acids by soluble epoxide hydrolase (sE...

Full description

Bibliographic Details
Main Authors:	Christophe Morisseau, Bora Inceoglu, Kara Schmelzer, Hsing-Ju Tsai, Steven L. Jinks, Christine M. Hegedus, Bruce D. Hammock
Format:	Article
Language:	English
Published:	Elsevier 2010-12-01
Series:	Journal of Lipid Research
Subjects:	soluble epoxide hydrolase central nervous system pain
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520313596

Similar Items

Soluble Epoxide Hydrolase Inhibition by <i>t</i>-TUCB Promotes Brown Adipogenesis and Reduces Serum Triglycerides in Diet-Induced Obesity
by: Haley Overby, et al.
Published: (2020-09-01)

The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification
by: Olivier Varennes, et al.
Published: (2020-06-01)

Differential Effects of 17,18-EEQ and 19,20-EDP Combined with Soluble Epoxide Hydrolase Inhibitor <i>t</i>-TUCB on Diet-Induced Obesity in Mice
by: Yang Yang, et al.
Published: (2021-07-01)

Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development
by: Cindy B. McReynolds, et al.
Published: (2021-08-01)

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients
by: Thomas Duflot, et al.
Published: (2019-03-01)

Activity of sEH and Oxidant Status during Systemic Bovine Coliform Mastitis
by: Vengai Mavangira, et al.
Published: (2021-05-01)

Inside epoxyeicosatrienoic acids and cardiovascular disease
by: Stefania eTacconelli, et al.
Published: (2014-11-01)

Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease
by: Aline Mello, et al.
Published: (2021-01-01)

Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues
by: Christophe Morisseau, et al.
Published: (2021-05-01)

Le rôle de l'Epoxyde hydrolase soluble (sEH) dans la physiopathologie des calcifications vasculaires
by: Varennes, Olivier
Published: (2018)

Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease
by: Hsueh-Te Lee, et al.
Published: (2019-12-01)

Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders
by: Qian Ren, et al.
Published: (2019-04-01)

In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea
by: Debin Wan, et al.
Published: (2019-05-01)

Effects of soluble epoxide hydrolase inhibitor on the expression of fatty acid synthase in peripheral blood mononuclear cell in patients with acute coronary syndrome
by: Zhao Xuan, et al.
Published: (2013-01-01)

ω-3 Polyunsaturated Fatty Acids on Colonic Inflammation and Colon Cancer: Roles of Lipid-Metabolizing Enzymes Involved
by: Maolin Tu, et al.
Published: (2020-10-01)

The Antihypertensive Effect of Quercetin in Young Spontaneously Hypertensive Rats; Role of Arachidonic Acid Metabolism
by: Fawzy Elbarbry, et al.
Published: (2020-09-01)

Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats
by: Jaroslav Hrdlička, et al.
Published: (2019-03-01)

The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension
by: Sean Shaw, et al.
Published: (2009-12-01)

Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats
by: Agnieszka Walkowska, et al.
Published: (2021-01-01)

Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity
by: Weibin Zha, et al.
Published: (2014-10-01)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
by: Cindy B. McReynolds, et al.
Published: (2019-05-01)

Effect Of Dual sEH/COX-2 Inhibition on Allergen-Induced Airway Inflammation
by: Mythili Dileepan, et al.
Published: (2019-09-01)

Association of the sEH gene promoter polymorphisms and haplotypes with preeclampsia
by: Sarı İsmail, et al.
Published: (2020-01-01)

Impact of a weight loss and fitness intervention on exercise‐associated plasma oxylipin patterns in obese, insulin‐resistant, sedentary women
by: Dmitry Grapov, et al.
Published: (2020-09-01)

Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy
by: Mercè Pallàs, et al.
Published: (2020-05-01)

Sexually Dimorphic Regulation of EET Synthesis and Metabolism: Roles of Estrogen
by: An Huang, et al.
Published: (2018-10-01)

Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage
by: Chun-Hu Wu, et al.
Published: (2017-11-01)

Deficiency of Soluble Epoxide Hydrolase Protects Cardiac Function Impaired by LPS-Induced Acute Inflammation
by: Victor Samokhvalov, et al.
Published: (2019-01-01)

Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction
by: Yajun Gui, et al.
Published: (2018-05-01)

A thiol redox sensor in soluble epoxide hydrolase enables oxidative activation by intra-protein disulfide bond formation
by: Rebecca L. Charles, et al.
Published: (2021-10-01)

Inhibition of soluble epoxide hydrolase by phytochemical constituents of the root bark of Ulmus davidiana var. japonica
by: Jang Hoon Kim, et al.
Published: (2021-01-01)

The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS
by: John W. Newman, et al.
Published: (2002-09-01)

Inhibitory Activity of Quercetin 3-<i>O</i>-Arabinofuranoside and 2-Oxopomolic Acid Derived from <i>Malus domestica</i> on Soluble Epoxide Hydrolase
by: In Sook Cho, et al.
Published: (2020-09-01)

In Vitro and In Silico Studies of Soluble Epoxide Hydrolase Inhibitors from the Roots of <i>Lycopus lucidus</i>
by: Yoo Kyong Han, et al.
Published: (2021-02-01)

Clinical significance of EPHX2 deregulation in prostate cancer
by: Ming-Sheng Liu, et al.
Published: (2021-01-01)

ZDHXB-101 (3′,5-Diallyl-2, 4′-dihydroxy-[1,1′-biphen-yl]-3,5′-dicarbaldehyde) protects against airway remodeling and hyperresponsiveness via inhibiting both the activation of the mitogen-activated protein kinase and the signal transducer and activator of transcription-3 signaling pathways
by: Jun-xia Jiang, et al.
Published: (2020-01-01)

Soluble epoxide hydrolase modulates immune responses in activated astrocytes involving regulation of STAT3 activity
by: Chia-Chi Hung, et al.
Published: (2019-06-01)

Inhibition potential of phenolic constituents from the aerial parts of Tetrastigma hemsleyanum against soluble epoxide hydrolase and nitric oxide synthase
by: Cai Yi Wang, et al.
Published: (2019-01-01)

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
by: Tamara Göbel, et al.
Published: (2019-03-01)

Soluble Epoxide Hydrolase Inhibitory Activity of Selaginellin Derivatives from Selaginella tamariscina
by: Jang Hoon Kim, et al.
Published: (2015-12-01)